Abstract:Skin sensitization is a critical end point in occupational toxicology that necessitates the use of fast, accurate, and affordable models to aid in establishing handling guidance for worker protection. While many in silico models have been developed, the scarcity of reliable data for active pharmaceutical ingredients (APIs) and their intermediates (together regarded as pharmaceutical compounds) brings into question the reliability of these tools, which are largely constructed using publicly available nonspecialty chemicals. Here, we present the quantum-mechanical (QM) Computer-Aided Discovery and REdesign (CADRE) model, which was developed with the bioactive and structurally complex chemical space in mind by relying on the fundamentals of chemical interactions in key events (versus structural attributes of training-set data). Validated in this study on 345 APIs and intermediates, CADRE achieved 95% accuracy, sensitivity, and specificity and a combined 79% accuracy in assigning potency categories compared to the mouse local lymph node assay data. We show how historical outcomes from CADRE testing in the pharmaceutical space, generated over the past 10 years on ca. 2500 chemicals, can be used to probe the relationships between sensitization mechanisms (or the underlying chemical classes) and the probability of eliciting a sensitization response in mice of a given potency. We believe this information to be of value to both practitioners, who can use it to quickly screen and triage their data sets, as well as to model developers to fine-tune their structure-based tools. Lastly, we leverage our experimentally validated subset of APIs and intermediates to show the importance of dermal permeability on the sensitization potential and potency. We demonstrate that common physicochemical properties used to assess permeation, such as the octanol-water partition coefficient and molecular weight, are poor proxies for the more accurate energy-pair distributions that can be computed from mixed QM and classical simulations using model representations of the stratum corneum.

Skin Sensitisation Case Study: Comparison of Defined Approaches including OECD 497 Guidance

How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497

Potency classification of isothiazolinone compounds based on defined approaches of skin sensitization in OECD GL 497

Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the "2 out of 3" Defined Approach

Computational application of internationally harmonized defined approaches to skin sensitization: DASS App

In Vitro Dendritic Cell-Based Test for Skin Sensitizers Identification and Potency Estimation

Increasing Accessibility of Bayesian Network-Based Defined Approaches for Skin Sensitisation Potency Assessment

The skin sensitization adverse outcome pathway: exploring the role of mechanistic understanding for higher tier risk assessment

Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds

Deriving a Continuous Point of Departure for Skin Sensitization Risk Assessment Using a Bayesian Network Model

A ready-to-use integrated in vitro skin corrosion and irritation testing strategy using EpiSkin™ model in China

Updating Reaction Mechanistic Domains for Skin Sensitization: 1. Nucleophilic Skin Sensitizers

In Silico Prediction of Skin Sensitization for Compounds Via Flexible Evidence Combination Based on Machine Learning and Dempster-Shafer Theory

Hybrid optimal descriptors as a tool to predict skin sensitization in accordance to OECD principles

Development of an in silico evaluation system that quantitatively predicts skin sensitization using OECD Guideline No. 497 ITSv2 defined approach for skin sensitization classification

Signal transduction profile of chemical sensitisers in dendritic cells: An endpoint to be included in a cell-based in vitro alternative approach to hazard identification?

Deriving a Point of Departure for Assessing the Skin Sensitization Risk of Wearable Device Constituents with In Vitro Methods

Development of an in chemico high-throughput screening method for the identification of skin sensitization potential

Performance of the DASF compared to other combinations of OECD NAMs for eye hazard identification of surfactants

An epidermal equivalent assay for identification and ranking potency of contact sensitizers

Prediction of skin sensitization using machine learning